Figure 4
Figure 4. Quantification of NK cells in whole blood from different clinical groups. Whole blood from HC (n = 16), patients with HUS (n = 14), UC (n = 5), and IC (n = 6) was stained with PECy5-labeled anti-CD3 and PE-labeled anti-CD56 and analyzed by flow cytometry as described in “Patients, materials, and methods.” (A) Representative dotplots from 1 child within each clinical group showing NK (CD3−CD56+) and NKT (CD3+CD56+) subpopulations in the lymphocyte gate. Dot plot quadrants are defined as: CD3+/CD56+, top right; CD3−/CD56+, top left; and CD3+/CD16−, bottom right. The percentages of the different subpopulations are shown within each quadrant. (B) Each bar represents the mean ± SEM of the percentage of NK cells (CD3−CD56+) relative to lymphocytes. *P < .005 compared with MC.

Quantification of NK cells in whole blood from different clinical groups. Whole blood from HC (n = 16), patients with HUS (n = 14), UC (n = 5), and IC (n = 6) was stained with PECy5-labeled anti-CD3 and PE-labeled anti-CD56 and analyzed by flow cytometry as described in “Patients, materials, and methods.” (A) Representative dotplots from 1 child within each clinical group showing NK (CD3CD56+) and NKT (CD3+CD56+) subpopulations in the lymphocyte gate. Dot plot quadrants are defined as: CD3+/CD56+, top right; CD3/CD56+, top left; and CD3+/CD16, bottom right. The percentages of the different subpopulations are shown within each quadrant. (B) Each bar represents the mean ± SEM of the percentage of NK cells (CD3CD56+) relative to lymphocytes. *P < .005 compared with MC.

Close Modal

or Create an Account

Close Modal
Close Modal